Lactylation drives tumor progression and immune evasion in triple negative breast cancer

4 weeks ago 14

Breast cancer maintains its position as the most prevalent malignancy in women worldwide, with triple-negative breast cancer (TNBC) representing the most treatment-resistant subtype due to limited therapeutic targets and frequent relapse.

1. Homepage
2. Breast Cancer
3. Lactylation drives tumor progression and immune evasion in triple negative breast cancer